Medical therapeutics stock Aethlon Medical, Inc. (Nasdaq: AEMD) reports publication of a pre-clinical study in the peer-reviewed journal
Preclinical Data Suggests Expanded Therapeutic Potential of the Hemopurifier® Beyond Virology and Oncology Results Support Further Evaluation of the Hemopurifier® as Part of a Machine Perfusion Circuit to Further Assess…